A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

NCT04685226 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: ICP-723

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd.